Mavacamten for hypertrophic cardiomyopathy: effectiveness and value

Institute for Clinical and Economic Review (ICER)
Record ID 32018002629
English
Details
Project Status: Completed
Year Published: 2021
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Cardiomyopathy, Hypertrophic
  • Cardiac Myosins
  • Cardiovascular Agents
  • Uracil
  • Cost-Benefit Analysis
  • Benzylamines
  • Adrenergic beta-Antagonists
Contact
Organisation Name: Institute for Clinical and Economic Review
Contact Address: 101 Merrimac St., 10th FL., Boston MA, USA 02114, Tel: (617) 724-4445 , Fax: (617) 726-9414
Contact Name: info@icer-review.org
Contact Email: info@icer-review.org
Copyright: <p>Institute for Clinical and Economic Review (ICER)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.